Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, supplying promising improvements throughout various health care and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, far more responsible alternative for therape